Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Stomach Neoplasms 4Thyroid Neoplasms 2Oropharyngeal Neoplasms 2NSCLC 2Lung Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymic epithelial tumor 1Spinal Metastasis 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrence 1Prostatic Neoplasms 1Pilonidal Sinus 1Pathologic Complete Response 1Pancoast Syndrome 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Mouth Neoplasms 1Microsatellite Instability 1

Interventions

Drug Therapy 2trilaciclib 1anlotinib 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Limited Stage Small Cell Lung Cancer × Surgical Procedures, Operative × Clear all
NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Not yet recruiting
348 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡